These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 20714888)

  • 41. Update on incretin hormones.
    Phillips LK; Prins JB
    Ann N Y Acad Sci; 2011 Dec; 1243():E55-74. PubMed ID: 22545749
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Incretin and bone].
    Yamada Y
    Clin Calcium; 2009 Sep; 19(9):1312-7. PubMed ID: 19721203
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of incretin hormones on beta-cell function in subjects with normal or impaired glucose tolerance.
    Muscelli E; Mari A; Natali A; Astiarraga BD; Camastra S; Frascerra S; Holst JJ; Ferrannini E
    Am J Physiol Endocrinol Metab; 2006 Dec; 291(6):E1144-50. PubMed ID: 16478775
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Four weeks of near-normalization of blood glucose has no effect on postprandial GLP-1 and GIP secretion, but augments pancreatic B-cell responsiveness to a meal in patients with Type 2 diabetes.
    Højberg PV; Vilsbøll T; Zander M; Knop FK; Krarup T; Vølund A; Holst JJ; Madsbad S
    Diabet Med; 2008 Nov; 25(11):1268-75. PubMed ID: 19046215
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Global biochemical profiling identifies β-hydroxypyruvate as a potential mediator of type 2 diabetes in mice and humans.
    Zhang S; Wang S; Puhl MD; Jiang X; Hyrc KL; Laciny E; Wallendorf MJ; Pappan KL; Coyle JT; Wice BM
    Diabetes; 2015 Apr; 64(4):1383-94. PubMed ID: 25368100
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Incretin effect and glucagon responses to oral and intravenous glucose in patients with maturity-onset diabetes of the young--type 2 and type 3.
    Østoft SH; Bagger JI; Hansen T; Pedersen O; Holst JJ; Knop FK; Vilsbøll T
    Diabetes; 2014 Aug; 63(8):2838-44. PubMed ID: 24677712
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glucose-dependent insulinotropic polypeptide: effects on insulin and glucagon secretion in humans.
    Christensen MB
    Dan Med J; 2016 Apr; 63(4):. PubMed ID: 27034187
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impaired incretin secretion and pancreatic dysfunction with older age and diabetes.
    Geloneze B; de Oliveira Mda S; Vasques AC; Novaes FS; Pareja JC; Tambascia MA
    Metabolism; 2014 Jul; 63(7):922-9. PubMed ID: 24854384
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Incretin hormones: Their role in health and disease.
    Nauck MA; Meier JJ
    Diabetes Obes Metab; 2018 Feb; 20 Suppl 1():5-21. PubMed ID: 29364588
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interplay between bone and incretin hormones: A review.
    Mabilleau G
    Morphologie; 2017 Mar; 101(332):9-18. PubMed ID: 27423214
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pancreatic islet dysfunction in type 2 diabetes: a rational target for incretin-based therapies.
    Meece J
    Curr Med Res Opin; 2007 Apr; 23(4):933-44. PubMed ID: 17407650
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Incretin concept revised: The origin of the insulinotropic function of glucagon-like peptide-1 - the gut, the islets or both?
    Yabe D; Seino Y; Seino Y
    J Diabetes Investig; 2018 Jan; 9(1):21-24. PubMed ID: 28746743
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Overview of incretin hormones.
    Efendic S; Portwood N
    Horm Metab Res; 2004; 36(11-12):742-6. PubMed ID: 15655702
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans.
    Holst JJ; Gromada J
    Am J Physiol Endocrinol Metab; 2004 Aug; 287(2):E199-206. PubMed ID: 15271645
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Incretin hormones and the up-regulation of insulin secretion in insulin resistance.
    Ahrén B
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1173-5. PubMed ID: 22493308
    [No Abstract]   [Full Text] [Related]  

  • 56. Incretin and Pancreatic β-Cell Function in Patients with Type 2 Diabetes.
    Ahn CH; Oh TJ; Min SH; Cho YM
    Endocrinol Metab (Seoul); 2023 Feb; 38(1):1-9. PubMed ID: 36781163
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effect of incretin hormones GIP and GLP-1 for the pathogenesis of type 2 diabetes mellitus].
    Vilsbøll T; Knop FK
    Ugeskr Laeger; 2007 May; 169(22):2101-5. PubMed ID: 17553392
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Activation of sodium-glucose cotransporter 1 ameliorates hyperglycemia by mediating incretin secretion in mice.
    Moriya R; Shirakura T; Ito J; Mashiko S; Seo T
    Am J Physiol Endocrinol Metab; 2009 Dec; 297(6):E1358-65. PubMed ID: 19808907
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Patients With Long-QT Syndrome Caused by Impaired
    Hyltén-Cavallius L; Iepsen EW; Wewer Albrechtsen NJ; Svendstrup M; Lubberding AF; Hartmann B; Jespersen T; Linneberg A; Christiansen M; Vestergaard H; Pedersen O; Holst JJ; Kanters JK; Hansen T; Torekov SS
    Circulation; 2017 May; 135(18):1705-1719. PubMed ID: 28235848
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparing olive oil and C4-dietary oil, a prodrug for the GPR119 agonist, 2-oleoyl glycerol, less energy intake of the latter is needed to stimulate incretin hormone secretion in overweight subjects with type 2 diabetes.
    Mandøe MJ; Hansen KB; Windeløv JA; Knop FK; Rehfeld JF; Rosenkilde MM; Holst JJ; Hansen HS
    Nutr Diabetes; 2018 Jan; 8(1):2. PubMed ID: 29330461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.